[ESPR] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
10-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -6.15%
YoY- -87.21%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/03 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -45,219 -17,402 -12,801 -9,806 -5,238 -3,351 -6,563 14.76%
Tax 606 488 378 164 168 362 578 0.33%
NP -45,219 -17,402 -12,801 -9,806 -5,238 -3,351 -6,563 14.76%
Tax Rate - - - - - - - -
Total Cost 45,219 17,402 12,801 9,806 5,238 3,351 6,563 14.76%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/03 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/03 CAGR
EPS -1.86 -0.77 -0.57 -0.64 -0.34 -0.35 -1.42 1.94%
EPS Diluted -1.86 -0.77 -0.57 -0.64 -0.34 -0.35 -1.42 1.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.